Yehuda Shoenfeld is the founder and former head of the Zabludowicz Center for Autoimmune Diseases, at the Sheba Medical Center, which is affiliated to the Sackler Faculty of Medicine in Tel-Aviv University, in Israel. Professor Shoenfeld is also the Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases at the Tel-Aviv University. Professor Shoenfeld’s clinical and scientific works focus on autoimmune and rheumatic diseases, and he has published more than 2280 papers in journals such as New Eng J Med, Nature, Lancet, Proc Nat Acad Scie, J Clin Invest, J Immunol, Blood, FASEB, J Exp Med, Circulation, Cancer and others. His articles have had over 83,000 citations. His Scopus h-index is 125. He has written more than 350 chapters in books, and has authored and edited 40 books, some of which became cornerstones in science and clinical practice, such as "The Mosaic of Autoimmunity", "Infections and Autoimmunity" and the textbook "Autoantibodies" and "Diagnostic criteria of autoimmune diseases", all of which were published by Elsevier and sold thousands of copies. Professor Shoenfeldis on the editorial boards of 43 journals in the field of rheumatology and autoimmunity and is the founder and the editor of the IMAJ (Israel Medical Association Journal) the representative journal of science and medicine in the English language in Israel, and also is the founder and Editor of Autoimmunity Reviews (Elsevier) (Impact factor 9.975) and co-Editor of the Journal of Autoimmunity (Impact factor 7.094). For the last twenty years Professor Shoenfeld has been the Editor of “Harefuah” – The Israel journal in medicine (Hebrew). Professor Shoenfeld received the EULAR prize in 2005, in Vienna, Austria: "The infectious etiologyof anti-phospholipid syndrome", and received a gold medal from the Slovak Society of Physicians for his contribution to Israel – Slovakia collaboration (March 2006). He is also an honorary member of the Hungarian Association of Rheumatology and the Royal Society of Physicians (UK). In UC Davis, USA, Professor Shoenfeld received the Nelson's Prize for Humanity and Science for 2008. In 2009 he was honoured as Doctoris Honoris Causa, from Debrecen University (Hungary) and Hasselt University in Belgium (2018), and from 2009 he is honorary member of the Slovenian National Academy of Sciences. He was recently awarded a Life Contribution Prize in Internal Medicine in Israel, 2012 as well as the ACR Master Award in 2013.In 2018 he was elected to the Israeli Academy of Sciences.In 2021 he was nominated as a President of Ariel University in Israel, Professor Shoenfeld has educated a long list of students with >55 becoming heads of departments and institutes.

Dr Cho’s main research interests have been focusing on cancer studies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. As a seasoned researcher, Dr Cho hasconducted cancer research in using molecular biology, proteomics, genomics, immunology as well as bioinformatics, his current H-index is 65. Dr Cho has published hundreds of peer-reviewed papers (Lancet Oncology, Annals of Oncology, Lancet Gastroenterology & Hepatology, Advanced Science, Nature Communications,PNAS,Journal of the National Cancer Institute,Journal of Extracellular Vesicles, Clinical Cancer Research, Clinical Chemistry, Molecular Cancer, Theranostics, etc) covering cancer biomarkers, proteomics, microRNAs, Chinese medicine and dozens of books including "MicroRNAs in Cancer Translational Research", "An Omics Perspective on Cancer Research", "Supportive Cancer Care with Chinese Medicine", “Drug Repurposing in Cancer Therapy: Approaches and Applications” etc.These papers have received > 15,000 citations.

Paolo’s research interests are in the economics of health promotion, particularly system-level policy and environmental interventions to promote physical activity and reduce obesity in the general population. Paolo was awarded his PhD in Health Economics in 2019 by the University of Leeds (UK). His PhD studies focused on the decision-analytic modelling for economic evaluation and health equity impacts of universal programmes to promote healthy behaviors. Following a three-year Post DOc at the Health Economics Research Centre, University of Oxford, Paolo joined the new Centre for Economics of Obesity at the University of Birmingham where he currently leads the Active Travel and Economic Modelling workstreams.